Julie Anne Overton

Director of Communications

Therapeutic Areas

Drug	Indication	Phase
CyPath® Lung	Early-stage lung cancer diagnosis	Commercial (LDT)
Platform Expansion	Other Cancers / Lung Diseases (COPD, Asthma)	Research
Therapeutic Discovery (siRNA)	Targeted Cancer Treatment	Discovery/Preclinical